A new tool covering baseline retinal characteristics improves risk assessment for age-related macular degeneration, according to a report in the Archives of Ophthalmology. Previous risk models have ...

Background The standard of care for neovascular age-related macular degeneration (nAMD) is repeated intravitreal injection ...

Older diabetic patients on two GLP-1 drugs showed an increased risk of neovascular age-related macular degeneration in an observational cohort study. The absolute risk was small, however, reaching 0.2 ...

Pachydrusen-associated AMD may progress slower than typical AMD. Age and macular pigment changes increase the risk of complications. Current AMD risk models may not apply to eyes with pachydrusen. AMD ...

Age-related macular degeneration blinds more older adults in Western countries than any other retinal disease. Neovascular AMD, while less common than its dry counterpart, causes nearly all cases of ...

A new study published in Nature Communications reveals the specific genetic factors linked to the presence of reticular pseudodrusen—deposits that drive vision loss and are found on the retina of up ...

Macular degeneration is the leading cause of vision loss in people older than 65. Smoking doubles your risk of macular degeneration compared to non-smokers. Your risk of the disease increases if you ...

A macular hole may progress through four stages, each with different features. An early stage hole may resolve without treatment, while a later stage hole typically requires surgery. The macula is a ...

Preliminary studies suggest GLP-1s may offer long-term vision protection for people without diabetes, but researchers caution more research is still needed. During a 10-year study, people without ...

Zia Sherrell is a health journalist, copywriter, and freelance writing mentor with over 1 million published words across major publications, including Healthline, Medical News Today, Business Insider, ...